Stock Events

Stock Events

Merck 

$135.97
9397
+$0.13+0.1% Monday 19:59
-$0.07-0.05%Monday 23:57After hours

Statistics

Day High
137.16
Day Low
134.55
52W High
137.16
52W Low
77.58
Volume
5,627,196
Avg. Volume
10,202,301
Mkt Cap
335.46B
P/E Ratio
34.8
Dividend Yield
2.5%
Dividend
3.4

Upcoming

Dividends

2.5%Dividend Yield
Jul 26
$0.85
Apr 26
$0.85
Jan 26
$0.85
Oct 25
$0.81
Jul 25
$0.81
10Y Growth
6.26%
5Y Growth
5.59%
3Y Growth
5.27%
1Y Growth
5%

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-1.47
-0.12
1.23
2.58
Expected EPS
2.216142
Actual EPS
N/A

Financials

28.08%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
65.01BRevenue
18.25BNet Income

Analyst Ratings

139.29Average Price Target
The highest estimate is 155.00.
From 14 ratings within the last 6 months. This is not an investment recommendation.
Buy
79%
Hold
21%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MRK. It's not an investment recommendation.
Microsoft
2180
MSFT
Realty Income
2130
O
Apple
1854
AAPL
Abbvie
1847
ABBV

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap152.69B
Pfizer competes directly with Merck in various therapeutic areas, including vaccines and oncology.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical segment, competes in areas such as immunology and cancer treatments.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline competes with Merck in the vaccines market and respiratory diseases.
Novartis
NVS
Mkt Cap286.78B
Novartis competes in multiple areas including oncology, neuroscience, and cardiovascular health.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie competes with Merck in areas such as immunology and oncology, particularly with its Humira product.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb competes in the oncology space, directly challenging Merck's Keytruda with its Opdivo.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly competes in the diabetes and cancer treatment markets, areas of focus for Merck.
AMGEN
AMGN
Mkt Cap224.63B
Amgen competes with Merck in areas such as oncology and cardiovascular diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its Genentech subsidiary, competes in oncology, including direct competition in the PD-L1 inhibitor space.
Sanofi
SNY
Mkt Cap104.76B
Sanofi competes with Merck in the diabetes, cardiovascular, and vaccines markets.

About

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Show more...
CEO
Robert Davis
Employees
75000
Country
United States
ISIN
US58933Y1055
WKN
000A0YD8Q

Listings

NEO
CA
MRK.NEO
BOATS
BOATS
MRK.BOATS
F
DE
6MK0.F
SN
CL
MRK.SN

0 Comments

Share your thoughts

FAQ

What is Merck stock price today?▼
The current price of MRK is $135.97 USD — it has increased by +0.1% in the past 24 hours. Watch Merck stock price performance more closely on the chart.
What is Merck stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Merck stocks are traded under the ticker MRK.
Is Merck stock price growing?▼
MRK stock has risen by +4.26% compared to the previous week, the month change is a +6.64% rise, over the last year Merck has showed a +61.45% increase.
What is Merck market cap?▼
Today Merck has the market capitalization of 335.46B
When is the next Merck earnings date?▼
Merck is going to release the next earnings report on October 29, 2026.
What were Merck earnings last quarter?▼
MRK earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.27 USD resulting in a +51.94% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Merck revenue for the last year?▼
Merck revenue for the last year amounts to 65.01B USD.
What is Merck net income for the last year?▼
MRK net income for the last year is 18.25B USD.
Does Merck pay dividends?▼
Yes, MRK dividends are paid quarterly. The last dividend per share was 0.85 USD. As of today, Dividend Yield (FWD)% is 2.5%.
How many employees does Merck have?▼
As of August 18, 2026, the company has 75,000 employees.
In which sector is Merck located?▼
Merck operates in the Health & Wellness sector.
When did Merck complete a stock split?▼
Merck has not had any recent stock splits.
Where is Merck headquartered?▼
Merck is headquartered in RAHWAY, United States.